Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2020	Mar. 31, 2020
ASSETS
Cash and cash equivalents	$ 10,622	$ 6,790
Restricted cash and cash equivalents	1,446	1,739
Investments in marketable securities	4,596	3,820
Finance receivables, net of allowance for credit losses of $1,162 and $727	78,800	73,996
Investments in operating leases, net	36,294	36,387
Other assets	2,733	2,823
Total assets	134,491	125,555
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	108,972	97,740
Deferred income taxes	3,589	5,458
Other liabilities	5,937	7,854
Total liabilities	118,498	111,052
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at December 31, 2020 and March 31, 2020	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive income	26	15
Retained earnings	15,050	13,571
Total shareholder's equity	15,993	14,503
Total liabilities and shareholder's equity	$ 134,491	$ 125,555